November 17, 2018
- Nuvaring (etonogestrel-ethinyl estradiol) – for birth control
- Zyclara (imiquimod cream 3.75%) – for skin disorders
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmaceutical News
November 16, 2018
November 16, 2018 – The U.S. FDA has approved TemixysTM (300mg lamivudine/300mg tenofovir disoproxil fumarate), manufactured by Celltrion, for use in combination with other antiretroviral agents to treat HIV-1 infection in adults and pediatric patients who weigh at least 35kg (77 pounds).